Skip to content
Case report

Infantile Osteopetrosis with a CLCN7 Variant: An Educational Case Highlighting Integrated Diagnosis and Variant Interpretation

Aug 2026 · EJIFCC · Vol 37, pp. 753 - 758 · 0 citations · 8 references
Medicine

TL;DR

This report presents an educational case emphasizing the importance of integrated clinical, radiological, and laboratory evaluation, and highlights the challenges in interpreting variants of uncertain significance in clinical practice.

Abstract

Background Infantile osteopetrosis is a rare inherited disorder caused by defective osteoclast-mediated bone resorption, resulting in increased bone density and marrow failure. The CLCN7 gene encodes a chloride channel essential for osteoclast acidification. Case Presentation A 4-month-old male presented with failure to thrive, pallor, hepatosplenomegaly, and recurrent infections. Examination revealed frontal bossing and hypotonia. Laboratory evaluation showed anemia and persistent hypocalcemia (6.8 mg/dL; reference 8.5–10.5 mg/dL). Skeletal survey demonstrated diffuse osteosclerosis with a characteristic “bone-within-bone” appearance. Differential diagnoses, including storage disorders and leukemia, were excluded. Clinical exome sequencing identified a homozygous CLCN7 missense variant, c.613G>A (p.Gly205Arg), classified as a variant of uncertain significance (VUS) based on ACMG/AMP criteria (PM2, PP3). Conclusion Diagnosis in this case was primarily clinico-radiological, with genetic findings providing supportive evidence. This report presents an educational case emphasizing the importance of integrated clinical, radiological, and laboratory evaluation, and highlights the challenges in interpreting variants of uncertain significance in clinical practice.

View source

Similar papers

Case report Open access Aug 2026

Diffuse osteosclerosis in a patient with systemic mastocytosis

The differential causes of osteosclerosis and the pathogenesis of bone manifestations related to SM, along with subtype-specific SM treatment options are discussed, along with subtype-specific SM treatment options.

Huy H Do, Balasubramanian Krishnamurthy, Vivian Grill et al. · 0 citations
Open access Sep 2026

Leukodystrophy in Tanzania: A Case Study Highlighting Diagnostic Dilemmas and Clinical Implications

This case highlights the diagnostic challenges of suspected leukodystrophies in under‐resourced environments, where clinical suspicion often exceeds available diagnostic capacity and underscores the need for improved multidisciplinary collaboration and expanded diagnostic infrastructure to support timely diagnosis, cou...

William Nkenguye, Mujaheed Suleman, Jay Lodhia · 0 citations
Case report Open access Oct 2026

Pediatric Fabry disease revealed by early neuropathic symptoms: a case report

Abstract Fabry disease (FD) is a rare X-linked lysosomal storage disorder caused by α-galactosidase A deficiency, resulting in progressive glycosphingolipid accumulation and multisystem morbidity. Early pediatric manifestations are frequently overlooked, delaying treatment and increasing the risk of irreversible organ...

I. Mezdaoui, Abdelilah Radi, S. Babour et al. · 0 citations
Open access Sep 2026

Unmasking Mucopolysaccharidosis Type I in a Patient With Wolf–Hirschhorn Syndrome: Diagnostic Overshadowing

Mucopolysaccharidosis Type I (MPS I) is a rare lysosomal storage disorder caused by α‐l‐iduronidase deficiency, leading to glycosaminoglycan accumulation and multisystem involvement. Wolf–Hirschhorn Syndrome (WHS) is a chromosomal disorder characterized by growth delay, dysmorphism, and developmental impairment. Becaus...

Karla Cifuentes-Uribe, Sandrine Girard, R. Froissart et al. · 0 citations
Open access Sep 2026

Tumor-Induced Osteomalacia in a Patient with Metastatic Prostate Cancer Presenting with Refractory Hypophosphatemia

Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by fibroblast growth factor 23 (FGF23) overproduction, which leads to renal phosphate wasting and hypophosphatemia. Herein, we present the case of an 81-year-old man with metastatic prostate adenocarcinoma who presented with fatigue, diffuse bone...

Aparajita Roy, K. Mullins, A. Kyriakou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.